Welcome to our dedicated page for Petco Health & Wellness Company SEC filings (Ticker: WOOF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Petco Health and Wellness Company, Inc. (Nasdaq: WOOF) provides access to the company’s official regulatory disclosures, including annual, quarterly and current reports. Through filings such as Form 10-K and Form 10-Q, Petco reports detailed information on its net sales from products and from services and other revenue, gross profit, selling, general and administrative expenses, operating income or loss, interest expense, net income or loss and cash flows. These filings also present balance sheet data covering assets, liabilities and stockholders’ equity, along with information on lease obligations and senior secured credit facilities.
Petco frequently uses Form 8-K to furnish earnings press releases under Item 2.02 (Results of Operations and Financial Condition). These 8-K filings attach full-text earnings releases as exhibits and may also reference scheduled webcasts where management discusses quarterly or annual results. Other 8-K filings report matters such as participation in investor conferences and the results of stockholder votes at the annual meeting, including director elections, advisory votes on executive compensation and ratification of the independent registered public accounting firm.
For investors analyzing WOOF, the SEC filings are a primary source for understanding Petco’s financial performance, capital structure and governance. They detail the company’s use of non-GAAP measures such as Adjusted EBITDA and Free Cash Flow, along with reconciliations to the most comparable GAAP measures. Filings also include discussions of guidance assumptions, risk factors and forward-looking statements related to net sales, earnings outlooks, cost action plans and transformation efforts.
On Stock Titan, these filings are updated as they are made available through EDGAR, and AI-powered tools can help summarize lengthy documents, highlight key trends in revenue and profitability, and surface information on topics such as debt levels, lease commitments and stockholder voting outcomes. This allows users to review Petco’s historical and current disclosures efficiently while maintaining direct access to the underlying SEC documents.
SIMMONS SABRINA reported acquisition or exercise transactions in this Form 4 filing.
Petco Health & Wellness Company, Inc. granted Chief Financial Officer Sabrina Simmons 592,886 restricted stock units (RSUs) and 389,106 performance stock units (PSUs) on February 17, 2026 under its 2021 Equity Incentive Plan.
Each RSU represents one share of Class A common stock or its cash value and will vest in stages over three years: 34% after one year, then 16.5% at 18 months, two years, 30 months, and three years. The PSUs represent a target that can pay out from 0% to 200% of 389,106 shares based on Petco’s 20-day volume-weighted average trading price over a performance period ending February 3, 2029, and require continued employment through the vesting date.
Insana Giovanni reported acquisition or exercise transactions in this Form 4 filing.
Petco Health & Wellness Company, Inc. reported that executive Giovanni Insana received equity awards consisting of 189,724 restricted stock units and 124,514 performance stock units under the company’s 2021 Equity Incentive Plan. These awards were granted at a price of
The RSUs vest in stages from the first through the third anniversary of the
The PSU grant reflects a target of 124,514 units, with the actual number of shares earned ranging from
Petco Health & Wellness Company, Inc. Chief Executive Officer and director Joel D. Anderson reported acquiring 5,000 shares of Class A common stock on January 30, 2026 at $2.29 per share under the company’s 2021 Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3.
Following this purchase, he beneficially owned 3,231,281 Class A shares directly, which include 2,466,451 restricted stock units where each unit represents one share. He also reported indirect holdings of 853,304 shares by a 2020 Trust, 229,204 shares by a 2025 Trust, 7,874 shares by his son, and 495,706 shares by a Revocable Trust.
Petco Health and Wellness Company, Inc. appointed Glenn Murphy, previously Executive Chairman, as non-employee Chairman of the Board effective February 1, 2026. This change shifts his role from an executive position to an independent board leadership capacity.
In connection with the transition, Mr. Murphy will receive a lump sum payment of $9,615.38 as statutory pay under his May 13, 2024 offer letter and remains eligible for an annual bonus for fiscal 2025, payable when executive officer bonuses are paid. Petco also issued a press release on February 2, 2026 to publicly announce his appointment as Chairman.
Petco Health and Wellness Company, Inc. entered into a Second Amendment to its First Lien Credit Agreement on February 2, 2026. New refinancing term loans of $900 million, together with cash and $600 million of 8.250% senior secured notes due 2031, will repay the existing term loan facility.
The refinancing term loans bear interest at Term Benchmark plus 4.25%, or at the Company’s option Base Rate plus 3.25%, include a 1.00% soft call premium on certain repricings within six months, amortize 1.00% per year, and mature five years after the amendment date. The 8.250% notes carry restrictive covenants and can be redeemed early at specified prices, including a make-whole premium before February 1, 2028.
Petco Health and Wellness Company, Inc. is issuing $600 million of 8.250% senior secured notes due 2031. The company expects the sale of these notes to close on February 2, 2026, subject to customary closing conditions.
The notes will be guaranteed by subsidiaries that already guarantee Petco’s credit facilities. They will be secured with first-lien priority on fixed assets and second-lien priority on current assets, and will sit at different levels of priority versus other existing secured and unsecured debt depending on collateral and lien ranking.
Petco plans to use the net proceeds from the notes, together with borrowings under a new term loan facility and cash on hand, to fully repay its existing term loan facility, cover related fees and expenses, and for general corporate purposes. The company announced these financing plans through a press release furnished as an exhibit.
Petco Health and Wellness Company, Inc. plans to raise
The company intends to use the net proceeds from the notes, together with borrowings under a new term loan facility and cash on hand, to repay its existing term loan facility in full, cover related fees and expenses, and support general corporate purposes.
Petco Health and Wellness Company, Inc. filed a current report to disclose that it has launched a debt refinancing transaction and issued a press release about this step. At the same time, the company reaffirmed its previously provided fourth quarter and full fiscal year 2025 outlook for Net Sales and Adjusted EBITDA, indicating that its expectations for sales and profitability measures remain unchanged.
The press release containing further details is included as Exhibit 99.1 to the report and is furnished under a section that is not treated as filed for liability purposes under the Securities Exchange Act.
Petco Health and Wellness Company, Inc. (WOOF) filed a Form 8-K announcing that it issued a press release with its financial results for the quarter ended November 1, 2025. The press release is provided as Exhibit 99.1.
The company scheduled a webcast call at 4:30 p.m. Eastern Time on November 25, 2025 to discuss these results, with an accompanying earnings presentation and replay available on its investor relations website. The information furnished under Items 2.02 and 7.01, including Exhibit 99.1, is designated as furnished rather than filed under the Exchange Act.
Petco Health & Wellness Company, Inc. (WOOF)55,249 shares of Class A common stock withheld, reported as a disposition, at a price of $2.81 per share. This withholding was used to satisfy the reporting person's tax liability related to previously granted restricted stock units (RSUs).
The RSUs were originally granted on November 18, 2024 under Petco’s 2021 Equity Incentive Plan, and a portion vested on November 18, 2025. After this tax withholding transaction, the officer beneficially owned 549,040 shares of Class A common stock, which includes 474,848 outstanding RSUs, with each RSU representing the right to receive one share of Class A common stock.